The store will not work correctly when cookies are disabled.
N-[4-(Diethylamino)phenyl]-3-methyl-5-phenylisoxazole-4-carboxamide
ID: ALA4589828
PubChem CID: 155568197
Max Phase: Preclinical
Molecular Formula: C21H23N3O2
Molecular Weight: 349.43
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCN(CC)c1ccc(NC(=O)c2c(C)noc2-c2ccccc2)cc1
Standard InChI: InChI=1S/C21H23N3O2/c1-4-24(5-2)18-13-11-17(12-14-18)22-21(25)19-15(3)23-26-20(19)16-9-7-6-8-10-16/h6-14H,4-5H2,1-3H3,(H,22,25)
Standard InChI Key: YEGWYDCWDGHERU-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
28.3523 -3.1226 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.3461 -3.9439 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.1250 -4.2041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6163 -3.5448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1350 -2.8783 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4334 -3.5508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8473 -2.8462 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.8368 -4.2616 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.6539 -4.2676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0553 -4.9804 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8717 -4.9869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2864 -4.2817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8787 -3.5686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0636 -3.5657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1036 -4.2867 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.5078 -4.9969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3250 -5.0019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5165 -3.5815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3337 -3.5865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3697 -4.9838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3910 -2.1038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1929 -1.9408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4512 -1.1663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9085 -0.5541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1044 -0.7216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8498 -1.4960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 1 1 0
4 6 1 0
6 7 2 0
6 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
12 15 1 0
15 16 1 0
16 17 1 0
15 18 1 0
18 19 1 0
3 20 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
5 21 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 349.43 | Molecular Weight (Monoisotopic): 349.1790 | AlogP: 4.75 | #Rotatable Bonds: 6 |
Polar Surface Area: 58.37 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.90 | CX Basic pKa: 5.42 | CX LogP: 3.95 | CX LogD: 3.95 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.70 | Np Likeness Score: -1.68 |
References
1. Jumppanen M, Kinnunen SM, Välimäki MJ, Talman V, Auno S, Bruun T, Boije Af Gennäs G, Xhaard H, Aumüller IB, Ruskoaho H, Yli-Kauhaluoma J.. (2019) Synthesis, Identification, and Structure-Activity Relationship Analysis of GATA4 and NKX2-5 Protein-Protein Interaction Modulators., 62 (17): [PMID:31431011] [10.1021/acs.jmedchem.9b01086] |